These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6986982)

  • 1. Effects of structure of N-acyl-N-2-fluorenylhydroxylamines on arylhydroxamic acid acyltransferase, sulfotransferase, and deacylase activities, and on mutations in Salmonella typhimurium TA 1538.
    Weeks CE; Allaben WT; Tresp NM; Louie SC; Lazear EJ; King CM
    Cancer Res; 1980 Apr; 40(4):1204-11. PubMed ID: 6986982
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism of N-hydroxy-2-acetylaminofluorene mutagenicity in the Salmonella test system. Role of N-O acyltransferase and sulfotransferase from rat liver.
    Wirth PJ; Thorgeirsson SS
    Mol Pharmacol; 1981 Mar; 19(2):337-44. PubMed ID: 6939968
    [No Abstract]   [Full Text] [Related]  

  • 3. Sulfation in the metabolism and mutagenicity of N-hydroxy-2-fluorenylacetamide.
    Hinson JA; Andrews LS; Gillette JR
    Natl Cancer Inst Monogr; 1981 Dec; (58):113-6. PubMed ID: 6176868
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic activation and genotoxicity of N-hydroxy-2-acetylaminofluorene and N-hydroxyphenacetin derivatives in Reuber (H4-II-E) hepatoma cells.
    Glowinski IB; Sanderson ND; Hayashi S; Thorgeirsson SS
    Cancer Res; 1984 Mar; 44(3):1098-104. PubMed ID: 6692396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species difference in liver microsomal and cytosolic enzymes involved in mutagenic activation of N-hydroxy-N-2-fluorenylacetamide.
    Kaneda S; Seno T; Takeishi K
    J Natl Cancer Inst; 1981 Sep; 67(3):549-55. PubMed ID: 6944527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of arylhydroxamic acid acyltransferase in the mutagenicity of N-hydroxy-N-2-fluorenylacetamide in Salmonella typhimurium.
    Weeks CE; Allaben WT; Louie SC; Lazear EJ; King CM
    Cancer Res; 1978 Mar; 38(3):613-8. PubMed ID: 203386
    [No Abstract]   [Full Text] [Related]  

  • 7. Activation of N-hydroxyphenacetin to mutagenic and nucleic acid-binding metabolites by acyltransfer, deacylation, and sulfate conjugation.
    Vaught JB; McGarvey PB; Lee MS; Garner CD; Wang CY; Linsmaier-Bednar EM; King CM
    Cancer Res; 1981 Sep; 41(9 Pt 1):3424-9. PubMed ID: 7020926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of acetylator genotype on hepatic and extrahepatic acetylation, deacetylation, and sulfation of 2-aminofluorene, 2-acetylaminofluorene, and N-hydroxy-2-acetylaminofluorene in the inbred hamster.
    Hein DW; Kirlin WG; Ogolla F; Trinidad A; Thompson LK; Ferguson RJ
    Drug Metab Dispos; 1986; 14(5):566-73. PubMed ID: 2876863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N'-hydroxy-2-aminofluorene: the principal mutagen produced from N-hydroxy-2-acetylaminofluorene by a mammalian supernatant enzyme preparation.
    Stout DL; Baptist JN; Matney TS; Shaw CR
    Cancer Lett; 1976 May; 1(5):269-74. PubMed ID: 797443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminofluorene-DNA adduct formation in Salmonella typhimurium exposed to the carcinogen N-hydroxy-2-acetylaminofluorene.
    Beranek DT; White GL; Heflich RH; Beland FA
    Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5175-8. PubMed ID: 6752940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rat mammary gland carcinogenesis after local injection of N-hydroxy-N-acyl-2-aminofluorenes: relationship to metabolic activation.
    Allaben WT; Weeks CE; Weis CC; Burger GT; King CM
    Carcinogenesis; 1982; 3(3):233-40. PubMed ID: 7083466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic activation of 2-aminofluorene, 2-acetylaminofluorene and N-hydroxy-acetylaminofluorene to bacterial mutagens with mussel (Mytilus galloprovincialis) and carp (Cyprinus carpio) subcellular preparations.
    Kurelec B; Krca S
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1987; 88(1):171-7. PubMed ID: 2890481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of the ability of liver microsomes to activate N-2-fluorenylacetamide to a mutagen of Salmonella typhimurium during hepatocarcinogenesis.
    Stout DL; Becker FF
    Cancer Res; 1978 Aug; 38(8):2274-8. PubMed ID: 208764
    [No Abstract]   [Full Text] [Related]  

  • 14. The relationship of 2-acetamidofluorene mutagenicity in plate tests with its in vivo liver cell component distribution and its carcinogenic potential.
    McGregor D
    Mutat Res; 1975 Dec; 30(3):305-15. PubMed ID: 1105163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro metabolism and mutagenic activation of 2-acetylaminofluorene by subcellular liver fractions from Cotton rats.
    Schut HA; Thorgeirsson SS
    Cancer Res; 1978 Aug; 38(8):2501-7. PubMed ID: 352509
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanism-based inactivation of N-arylhydroxamic acid N,O-acyltransferase by 7-substituted-N-hydroxy-2-acetamidofluorenes.
    Marhevka VC; Ebner NA; Sehon RD; Hanna PE
    J Med Chem; 1985 Jan; 28(1):18-24. PubMed ID: 3965709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acetyltransferase multiplicity and the bioactivation of N-arylhydroxamic acids by hamster hepatic and intestinal enzymes.
    Smith TJ; Hanna PE
    Carcinogenesis; 1986 May; 7(5):697-702. PubMed ID: 3486051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary lipid-dependent activation of the carcinogen N-2-fluorenylacetamide in rats as monitored by Salmonella typhimurium.
    Castro CE; Felkner IC; Yang SP
    Cancer Res; 1978 Sep; 38(9):2836-41. PubMed ID: 354780
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolic activation of 2-acetylaminofluorene.
    Thorgeirsson SS; Wirth PJ; Staiano N; Smith CL
    Adv Exp Med Biol; 1981; 136 Pt B():897-919. PubMed ID: 7046390
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolism of N-hydroxy-2-acetylaminofluorene and N-hydroxy-2-aminofluorene by guinea pig liver microsomes.
    Razzouk C; Batardy-Grégoire M; Roberfroid M
    Cancer Res; 1982 Nov; 42(11):4712-8. PubMed ID: 7127306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.